167 related articles for article (PubMed ID: 17311349)
1. Rituximab for the treatment of childhood chronic idiopathic thrombocytopenic purpura and hemophilia with inhibitors.
Franchini M; Zaffanello M; Veneri D; Lippi G
Pediatr Blood Cancer; 2007 Jul; 49(1):6-10. PubMed ID: 17311349
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of rituximab in the treatment of inhibitor-associated hemostatic disorders.
Franchini M; Veneri D; Lippi G; Stenner R
Thromb Haemost; 2006 Aug; 96(2):119-25. PubMed ID: 16894452
[TBL] [Abstract][Full Text] [Related]
3. Rituximab in the treatment of autoimmune haematological disorders.
Garvey B
Br J Haematol; 2008 Apr; 141(2):149-69. PubMed ID: 18318765
[TBL] [Abstract][Full Text] [Related]
4. Rituximab in B-cell disorders other than non-Hodgkin's lymphoma.
Bosly A; Keating MJ; Stasi R; Bradstock K
Anticancer Drugs; 2002 Nov; 13 Suppl 2():S25-33. PubMed ID: 12710588
[TBL] [Abstract][Full Text] [Related]
5. Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura.
Bengtson KL; Skinner MA; Ware RE
J Pediatr; 2003 Nov; 143(5):670-3. PubMed ID: 14615744
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.
Santos ES; Arosemena LR; Raez LE; O'Brien C; Regev A
Liver Int; 2006 Jun; 26(5):625-9. PubMed ID: 16762009
[TBL] [Abstract][Full Text] [Related]
7. Veltuzumab, an anti-CD20 mAb for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and immune thrombocytopenic purpura.
Milani C; Castillo J
Curr Opin Mol Ther; 2009 Apr; 11(2):200-7. PubMed ID: 19330725
[TBL] [Abstract][Full Text] [Related]
8. Rituximab treatment for chronic refractory idiopathic thrombocytopenic purpura.
Zhou Z; Yang R
Crit Rev Oncol Hematol; 2008 Jan; 65(1):21-31. PubMed ID: 17681784
[TBL] [Abstract][Full Text] [Related]
9. Rituximab in the treatment of relapsing idiopathic thrombocytopenic purpura.
Riksen NP; Keuning JJ; Vreugdenhil G
Neth J Med; 2003 Jul; 61(7):262-5. PubMed ID: 14567524
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in the treatment of adult acquired hemophilia A: a systematic review.
Franchini M
Crit Rev Oncol Hematol; 2007 Jul; 63(1):47-52. PubMed ID: 17236786
[TBL] [Abstract][Full Text] [Related]
11. Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?
Cooper N; Evangelista ML; Amadori S; Stasi R
Curr Opin Hematol; 2007 Nov; 14(6):642-6. PubMed ID: 17898569
[TBL] [Abstract][Full Text] [Related]
12. Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP).
Alasfoor K; Alrasheed M; Alsayegh F; Mousa SA
Ann Hematol; 2009 Mar; 88(3):239-43. PubMed ID: 18704420
[TBL] [Abstract][Full Text] [Related]
13. [Effective treatment with rituximab in a patient with refractory idiopathic thrombocytopenic purpura].
Tanai C; Iki S; Nakahara F; Iijima K; Usuki K; Kuwana M; Urabe A
Rinsho Ketsueki; 2004 Nov; 45(11):1181-6. PubMed ID: 15609684
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies in the treatment of autoimmune cytopenias.
Robak T
Eur J Haematol; 2004 Feb; 72(2):79-88. PubMed ID: 14962245
[TBL] [Abstract][Full Text] [Related]
15. A review of rituximab in cutaneous medicine.
Scheinfeld N
Dermatol Online J; 2006 Jan; 12(1):3. PubMed ID: 16638371
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for adolescents with haemophilia and high titre inhibitors.
Fox RA; Neufeld EJ; Bennett CM
Haemophilia; 2006 May; 12(3):218-22. PubMed ID: 16643204
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab.
Hensel M; Ho AD
Am J Hematol; 2003 May; 73(1):37-40. PubMed ID: 12701118
[TBL] [Abstract][Full Text] [Related]
18. Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood.
Taube T; Schmid H; Reinhard H; von Stackelberg A; Overberg US
Haematologica; 2005 Feb; 90(2):281-3. PubMed ID: 15710595
[TBL] [Abstract][Full Text] [Related]
19. Clinical remission following monoclonal anti-CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura.
Moschovi M; Trimis G; Pergantou H; Platokouki H; Vrachnou E; Tzortzatou-Stathopoulou F
J Paediatr Child Health; 2005 Jul; 41(7):384-6. PubMed ID: 16014149
[TBL] [Abstract][Full Text] [Related]
20. Rituximab in the management of chronic immune thrombocytopenic purpura: what is its place?
Ducassou S; Aladjidi N; Lutz P
Pediatr Blood Cancer; 2010 Apr; 54(4):632. PubMed ID: 19953650
[No Abstract] [Full Text] [Related]
[Next] [New Search]
